Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

NCT05353894 is registered in ClinicalTrials.gov with Genoscience Pharma as lead sponsor.

NCT NCT05353894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05353894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
Lead sponsor
Genoscience Pharma
Phase
Phase 1
Overall status
Unknown status
Start date
May 2, 2022
Completion date
November 30, 2022
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary liver cancer